The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
Chloroquine Resistance in Plasmodium vivax
Open accessAbstract
Emerging resistance to chloroquine (CQ) by Plasmodium vivax threatens the health of the hundreds of millions of people routinely exposed to the risk of infection with this organism. CQ has been the first-line therapy for vivax malaria since 1946 (32, 115). Plasmodium falciparum developed resistance to CQ in the 1950s (110), and today it occurs globally (91). Resistance by P. vivax was unknown until 1989, when Australians repatriated from Papua New Guinea failed routine treatment (94). Subsequent reports affirmed that finding, and CQ-resistant P. vivax (CRPV) was reported from Indonesia (8, 35, 99, 100, 111). Reports from Myanmar (76, 82) and India (56, 107) followed. CRPV appeared in travelers from Guyana, South America (88). However, studies in Thailand (38, 72, 103), the Philippines (10), and Vietnam (105) revealed only CQ-sensitive P. vivax. Surveys in Indonesia revealed a low frequency of CRPV in the west (~10%) (15, 16, 49, 50, 51, 53, 75) and a higher risk in the east (~45%) (9, 18, 52, 81, 102, 106). This minireview summarizes the present state of knowledge of CRPV as a scientific, clinical, and public health problem. It examines the genesis of CQ therapy for P. vivax and the laboratory and clinical data underpinning the diagnosis of CRPV. The available data showing the global distribution of CRPV are listed. Finally, the clinical data on alternative therapies against CRPV are reviewed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The neglected burden of Plasmodium vivax malaria
Mendis, K., Sina, B., Marchesini, P., & Carter, R. (2001) · The American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2001.64.97 · Cited by 970
Wellems, T. E., & Plowe, C. V. (2001) · The Journal of Infectious Diseases · doi:10.1086/322858 · Cited by 807
Anderson, T. J. C., Haubold, B., Williams, J. T., Estrada-Franco§, J. G., Richardson, L., Mollinedo, R., Bockarie, M., Mokili, J., Mharakurwa, S., French, N., et al. (2000) · Molecular Biology and Evolution · doi:10.1093/oxfordjournals.molbev.a026247 · Cited by 779
PLASMODIUM VIVAX RESISTANCE TO CHLOROQUINE?
Rieckmann, K. H., Davis, D. R., & Hutton, D. C. (1989) · The Lancet · doi:10.1016/s0140-6736(89)91792-3 · Cited by 501
Primaquine Therapy for Malaria
Baird, J. K., & Hoffman, S. L. (2004) · Clinical Infectious Diseases · doi:10.1086/424663 · Cited by 435
Self-citationResistance to Chloroquine by Plasmodium vivax in Irian Jaya, Indonesia
Baird, J. K., Basri, H., Purnomo, Bangs, M. J., Subianto, B., Patchen, L. C., & Hoffman, S. L. (1991) · The American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.1991.44.547 · Cited by 232
Self-citationVivax malaria resistant to treatment and prophylaxis with chloroquine
Murphy, G. S., Basri, H., Andersen, E. M., Bangs, M. J., Gorden, J., Sorensen, K., Mount, D. L., Lal, A. A., Purwokusumo, A. R., Harjosuwarno, S., et al. (1993) · The Lancet · doi:10.1016/0140-6736(93)92568-e · Cited by 209
Pitfalls in a Discovery: The Chronicle of Chloroquine
Coatney, G. R. (1963) · The American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.1963.12.121 · Cited by 204
Baird, J. K., Leksana, B., Masbar, S., Fryauff, D. J., Sutanihardja, M. A., Suradi, Wignall, F. S., & Hoffman, S. L. (1997) · The American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.1997.56.621 · Cited by 171
Self-citationOhrt, C., Richie, T. L., Widjaja, H., Shanks, G. D., Fitriadi, J., Fryauff, D. J., Handschin, J., Tang, D., Sandjaja, B., Tjitra, E., et al. (1997) · Annals of Internal Medicine · doi:10.7326/0003-4819-126-12-199706150-00006 · Cited by 164
Cited by
Vivax Malaria: Neglected and Not Benign
Price, R. N., Tjitra, E., Guerra, C. A., Yeung, S., White, N. J., & Anstey, N. M. (2007) · The American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.2007.77.79 · Cited by 838
Key gaps in the knowledge of Plasmodium vivax, a neglected human malaria parasite
Mueller, I., Galinski, M. R., Baird, J. K., Carlton, J. M., Kochar, D. K., Alonso, P. L., & del Portillo, H. A. (2009) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(09)70177-x · Cited by 661
Self-citationTjitra, E., Anstey, N. M., Sugiarto, P., Warikar, N., Kenangalem, E., Karyana, M., Lampah, D. A., & Price, R. N. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050128 · Cited by 611
The pathophysiology of vivax malaria
Anstey, N. M., Russell, B., Yeo, T. W., & Price, R. N. (2009) · Trends in Parasitology · doi:10.1016/j.pt.2009.02.003 · Cited by 428
Global Epidemiology of Plasmodium vivax
Howes, R. E., Battle, K. E., Mendis, K. N., Smith, D. L., Cibulskis, R. E., Baird, J. K., & Hay, S. I. (2016) · The American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.16-0141 · Cited by 418
Self-citationEffectiveness of Antimalarial Drugs
Baird, J. K. (2005) · New England Journal of Medicine · doi:10.1056/nejmra043207 · Cited by 375
Self-citationWHO Guidelines for the treatment of malaria
Kunte, R., & Kunwar, R. (2011) · Medical Journal Armed Forces India · doi:10.1016/s0377-1237(16)30022-3 · Cited by 341
Geographical variation in Plasmodium vivax relapse
Battle, K. E., Karhunen, M. S., Bhatt, S., Gething, P. W., Howes, R. E., Golding, N., Van Boeckel, T. P., Messina, J. P., Shanks, G. D., Smith, D. L., et al. (2014) · Malaria Journal · doi:10.1186/1475-2875-13-144 · Cited by 282
Self-citationUK malaria treatment guidelines
Lalloo, D. G., Shingadia, D., Pasvol, G., Chiodini, P. L., Whitty, C. J., Beeching, N. J., Hill, D. R., Warrell, D. A., & Bannister, B. A. (2007) · Journal of Infection · doi:10.1016/j.jinf.2006.12.003 · Cited by 272
Neglect of Plasmodium vivax malaria
Baird, J. K. (2007) · Trends in Parasitology · doi:10.1016/j.pt.2007.08.011 · Cited by 266
Self-citationResistance to Therapies for Infection by Plasmodium vivax
Baird, J. K. (2009) · Clinical Microbiology Reviews · doi:10.1128/cmr.00008-09 · Cited by 262
Self-citationMalaria ecology along the Thailand-Myanmar border.
Parker, D. M., Carrara, V. I., Pukrittayakamee, S., McGready, R., & Nosten, F. H. (2015) · Malaria Journal · doi:10.1186/s12936-015-0921-y · Cited by 142
Tarning, J., Chotsiri, P., Jullien, V., Rijken, M. J., Bergstrand, M., Cammas, M., McGready, R., Singhasivanon, P., Day, N. P. J., White, N. J., et al. (2012) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01242-12 · Cited by 51
Urban, P., & Fernandez-Busquets, X. (2014) · Current Medicinal Chemistry · doi:10.2174/09298673113206660292 · Cited by 39
Vivax malaria and chloroquine resistance: a neglected disease as an emerging threat
Waheed, A. A., Ghanchi, N. K., Rehman, K. A., Raza, A., Mahmood, S. F., & Beg, M. A. (2015) · Malaria Journal · doi:10.1186/s12936-015-0660-0 · Cited by 23
Radical Cure: The Case for Anti-Relapse Therapy Against All Malarias
Baird, J. K. (2011) · Clinical Infectious Diseases · doi:10.1093/cid/ciq258 · Cited by 12
“1058-4838/2011/525-0001$37.00 DOI: 10.1093/cid/ciq258 EDITORIAL COMMENTARY d CID 2011:52 (1 March) d 621 Figure 1, reprinted from Baird [7], illustrates this principle.”
Self-citation
Metadata
- Authors
- Baird, J. K.
- Venue
- Antimicrobial Agents and Chemotherapy
- Publisher
- American Society for Microbiology
- Published
- 2004-11
- Volume
- 48
- Issue
- 11
- Pages
- 4075-4083
- ISSN
- 0066-4804 (ISSN-L)
- 1098-6596
- OpenAlex
- W2169511625
- Cited by
- 335
- References
- 48
- FWCI
- 15.32
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.